rs9515185

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.19G>C​(p.Val7Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.409 in 1,473,912 control chromosomes in the GnomAD database, including 126,325 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 11147 hom., cov: 34)
Exomes 𝑓: 0.41 ( 115178 hom. )

Consequence

COL4A1
NM_001845.6 missense

Scores

1
1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.0290
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in the COL4A1 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 194 curated pathogenic missense variants (we use a threshold of 10). The gene has 77 curated benign missense variants. Gene score misZ: 3.0194 (below the threshold of 3.09). Trascript score misZ: 4.972 (above the threshold of 3.09). GenCC associations: The gene is linked to brain small vessel disease 1 with or without ocular anomalies, pontine autosomal dominant microangiopathy with leukoencephalopathy, muscular dystrophy-dystroglycanopathy, type A, microangiopathy and leukoencephalopathy, pontine, autosomal dominant, familial porencephaly, autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome, retinal arterial tortuosity.
BP4
Computational evidence support a benign effect (MetaRNN=3.4492954E-5).
BP6
Variant 13-110307009-C-G is Benign according to our data. Variant chr13-110307009-C-G is described in ClinVar as [Benign]. Clinvar id is 193216.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-110307009-C-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.61 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.19G>C p.Val7Leu missense_variant Exon 1 of 52 ENST00000375820.10 NP_001836.3
COL4A1NM_001303110.2 linkc.19G>C p.Val7Leu missense_variant Exon 1 of 25 NP_001290039.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.19G>C p.Val7Leu missense_variant Exon 1 of 52 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.372
AC:
56421
AN:
151854
Hom.:
11156
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.253
Gnomad AMI
AF:
0.357
Gnomad AMR
AF:
0.406
Gnomad ASJ
AF:
0.535
Gnomad EAS
AF:
0.628
Gnomad SAS
AF:
0.475
Gnomad FIN
AF:
0.280
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.413
Gnomad OTH
AF:
0.429
GnomAD3 exomes
AF:
0.435
AC:
36477
AN:
83772
Hom.:
8340
AF XY:
0.440
AC XY:
20975
AN XY:
47692
show subpopulations
Gnomad AFR exome
AF:
0.255
Gnomad AMR exome
AF:
0.393
Gnomad ASJ exome
AF:
0.553
Gnomad EAS exome
AF:
0.631
Gnomad SAS exome
AF:
0.466
Gnomad FIN exome
AF:
0.284
Gnomad NFE exome
AF:
0.417
Gnomad OTH exome
AF:
0.469
GnomAD4 exome
AF:
0.413
AC:
546481
AN:
1321950
Hom.:
115178
Cov.:
40
AF XY:
0.416
AC XY:
270622
AN XY:
651288
show subpopulations
Gnomad4 AFR exome
AF:
0.242
Gnomad4 AMR exome
AF:
0.403
Gnomad4 ASJ exome
AF:
0.558
Gnomad4 EAS exome
AF:
0.601
Gnomad4 SAS exome
AF:
0.462
Gnomad4 FIN exome
AF:
0.285
Gnomad4 NFE exome
AF:
0.409
Gnomad4 OTH exome
AF:
0.429
GnomAD4 genome
AF:
0.371
AC:
56406
AN:
151962
Hom.:
11147
Cov.:
34
AF XY:
0.372
AC XY:
27620
AN XY:
74272
show subpopulations
Gnomad4 AFR
AF:
0.253
Gnomad4 AMR
AF:
0.406
Gnomad4 ASJ
AF:
0.535
Gnomad4 EAS
AF:
0.628
Gnomad4 SAS
AF:
0.474
Gnomad4 FIN
AF:
0.280
Gnomad4 NFE
AF:
0.413
Gnomad4 OTH
AF:
0.424
Alfa
AF:
0.380
Hom.:
1412
Bravo
AF:
0.379
TwinsUK
AF:
0.402
AC:
1489
ALSPAC
AF:
0.407
AC:
1569
ExAC
AF:
0.340
AC:
7121
Asia WGS
AF:
0.500
AC:
1729
AN:
3466

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Jan 15, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

May 23, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 02, 2021
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Brain small vessel disease 1 with or without ocular anomalies Benign:3
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome Benign:2
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Porencephalic cyst Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
15
DANN
Benign
0.64
DEOGEN2
Benign
0.18
T;.
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.64
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.38
T;T
MetaRNN
Benign
0.000034
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.34
N;N
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
0.090
N;N
REVEL
Uncertain
0.29
Sift
Benign
0.57
T;T
Sift4G
Benign
0.98
T;T
Polyphen
0.0010
B;.
Vest4
0.040
MPC
0.38
ClinPred
0.0022
T
GERP RS
1.5
Varity_R
0.026
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs9515185; hg19: chr13-110959356; COSMIC: COSV64624437; COSMIC: COSV64624437; API